2022年3月17日简报:此轮本土传播以奥密克戎BA.2亚型为主,绝大多数为无症状感染;韩国日增40万例,死亡164人;BA.2株导致欧洲多国疫情反弹

2022-03-17 MedSci整理 MedSci整理

截至北京时间2022年3月17日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过4亿6318万例,新增1,623,730例,达到463,182

截至北京时间2022年3月17日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎COVID-19)病例超过4亿6318万例,新增1,623,730例,达到463,182,124例。累计死亡病例607.9万例,达到6,079,600例。新增死亡为4,807例。康复为395,991,313例,重症和危重症病人达到64,022例;全球新冠确诊病例超过100万例的国家和地区达56个,125个国家和地区病例超10万例。昨日报道:2022年3月16日简报:最新版新冠诊疗法方案公布,对轻症不必收治于定点医院;80%到90%奥密克戎感染者都是无症状的携带者;

美疾控中心:奥密克戎疫情致美国幼儿住院率上升

据美国合众国际社报道,当地时间15日,美国疾病控制与预防中心(CDC)表示,奥密克戎变异株感染率的增加导致4岁以下儿童住院率上升,是德尔塔变异株引发疫情高峰期的五倍。

上海新增本土新冠肺炎确诊病例1例 新增本土无症状感染者19例

从上海市新冠肺炎疫情防控新闻发布会上获悉,上海市卫生健康委主任邬惊雷介绍道,截至今天15时上海新增本土新冠肺炎确诊病例1例,新增本土无症状感染者19例。

本轮本土感染以BA.2为主

3月15日,国务院联防联控机制举行新闻发布会,介绍疫情防控与疫苗接种工作有关情况。国家卫生健康委疾控局副局长、一级巡视员雷正龙表示,近两个月奥密克戎BA.2亚分支所占的比例明显增加,传播力也进一步增强,且感染者临床表现以无症状和轻型为主,导致疫情隐匿性传播,发现比较晚,造成近期的本土疫情频繁发生,给溯源和防控增加了难度。3月以来,我国至少9省报告在本土病例中发现了奥密克戎BA.2。 

浙江省召开第105场新冠肺炎疫情防控工作新闻发布会,会上通报本轮疫情特点。从疫情态势看,近期浙江省疫情呈局部点状散发、个别为聚集性疫情。截至目前,共发生9起疫情,7起为独立疫情,上城区和开化县的2起疫情与四季青服装市场进口衣物存在关联。从病毒溯源看,奥密克戎变异株BA.2亚型迅速发展成为浙江省本土疫情的主要流行株。9起疫情中,7起为奥密克戎BA.2进化分支,2起为奥密克戎BA.1.1进化分支,显示出BA.2亚型较以往病毒株更容易造成人体的感染和传播,且隐匿性增加

3月15日下午,南京市召开新冠肺炎疫情防控通气会。南京市卫健委副主任夏海鸣通报,3月10日以来,南京市江宁区、秦淮区部分地区发生外地来宁人员关联本土疫情,截至3月15日16时,南京本轮疫情共发现阳性人员32例。已出结果中,江宁区6例基因测序确认为奥密克戎变异株BA.2进化分支,其他测序和分析比对还在进一步分析中。

 

BA.2在全球多国的占比,欧洲多国疫情大幅反弹

丹麦是第一个通报BA.2取代BA.1的国家,在抽样分析的11万病例中,有超过8万人感染BA.2毒株,占比达到73%;而在瑞典抽样的两万二千余病例中,有超过47%的人感染了BA.2毒株。此外,在英国、列支敦士登、比利时、德国、荷兰和瑞士6个国家的抽样病例中,感染BA.2毒株的患者占比都超过10%。

欧洲多国因急于解封而面临疫情反弹的风险。随着更具传染性的奥密克戎亚型变异毒株BA.2迅速传播,德国感染率连续四天破纪录,奥地利病例也达到新高,荷兰病例则在解除几乎所有限制后翻了一倍。

而在亚洲,菲律宾则是BA.2扩散最快的国家。在病例抽样总数为1063人中,有965人感染了BA.2毒株,占比达到91%;尼泊尔、卡塔尔、印度、孟加拉国和柬埔寨五国,其感染BA.2毒株的患者占比都超过50%;此外,BA.2也成为斯里兰卡、格鲁吉亚、新加坡、文莱等国家的主要传播毒株,占比都接近50%。

在中国香港,感染BA.2毒株的患者占抽样分析总数的71%。

奥密克戎BA.2变种约占全美病例的四分之一

据CBSNews报道,感染奥密克戎BA.2变种病毒的病例,目前约占全美新冠感染病例的四分之一。

联邦疾病控制与预防中心(CDC)表示,奥密克戎BA.2变种病毒在纽约州(New York)和新泽西州(New Jersey)的传播尤其快速,约占新冠病例的39%左右。

奥密克戎BA.2变种正在成为全球的主导病毒,一些国家面临着新一波的病例激增,而此时他们正要取消新冠疫情限制措施。

以色列发现新冠新型变异株,结合了奥密克戎亚型变异株BA.1和BA.2的特征

海外网3月16日电据《耶路撒冷邮报》16日报道,以色列卫生部当日宣布,以色列两名患者身上检测出一种新型冠状病毒的新变异株,该毒株结合了奥密克戎亚型变异株BA.1和BA.2的特征。该新型变异株在世界其他国家还未有报告。

以色列卫生部总干事纳赫曼·阿什16日表示,该变异株是从入境航班旅客身上发现的,他们在抵达以色列前就已感染。目前尚不清楚该变异株的影响。

近期,多个欧洲国家出现奥密克戎和德尔塔变异株的混合毒株。世卫组织正对其进行监测,目前看来该重组毒株导致疾病的严重性没有变化

新冠大流行是否会成“地方病”?

伦敦大学卫生和热带医学院传染病流行病学教授戴维·海曼认为,新冠正在成为“地方病”,并且会继续流行一段时间——就像其他冠状病毒一样,“有四种冠状病毒已发展为‘地方病’”。

哈切特认为,流感是“地方病”,流感病毒随着时间的推移而演变,每年都会引起流行病。从长远来看,新冠病毒会表现得更像流感病毒一样,它会继续传播,会不断进化。

福奇认为,“地方病”是对社会秩序没有破坏性但并未被消除的传染病。福奇将大流行分为5个阶段,即大流行、减速、控制、消除、根除,迄今人类只根除过天花。“世界不会将戴口罩作为正常的状态。所谓的新常态意味着更好的控制。”他指出,新冠病毒不会完全消除,但人们需要将其控制到“不会破坏我们正常的社会、经济和其他活动”。

韩国日增新冠病例首次破40万例,死亡163例

韩国疾病管理厅16日通报,截至当天零时,韩国单日新增新冠确诊病例超过40万例,创下疫情暴发以来韩国日增病例数新高。目前,韩国累计新冠确诊病例数逼近763万例。

 据韩联社报道,作为疫情重要指标之一的重症病例数也达到创纪录的1244例,较前一天增加48例。韩国的重症病例数已连续9天超过1000例。

随着新冠病毒变异株奥密克戎肆虐,韩国疫情迅速恶化,日增确诊病例1月26日首次超过1万例后,相关统计数字屡破纪录。2月不到一个月时间里,韩国累计确诊病例数先后突破100万例、200万例和300万例关口。进入3月,疫情不见好转,日增确诊病例数维持在高位,多日超过30万例。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1334933, encodeId=a471133493302, content=<a href='/topic/show?id=d16910002215' target=_blank style='color:#2F92EE;'>#韩国#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100022, encryptionId=d16910002215, topicName=韩国)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99cf2500102, createdName=zjshifan_98647306, createdTime=Fri Mar 18 22:40:10 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1339447, encodeId=907c133944e2f, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63054, encryptionId=447663054f5, topicName=欧洲)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKxsKDoOOFxGpMibw6lsQFUIicWt7kWGevkdgFhjiban1icD2JdIBmjVo7qX7aSlCSpiaia382nuLKiaI3Cg/132, createdBy=5c442500150, createdName=ms9474365431325850, createdTime=Fri Mar 18 22:40:10 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1485247, encodeId=312b148524e86, content=<a href='/topic/show?id=4bbe5902ed2' target=_blank style='color:#2F92EE;'>#无症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59027, encryptionId=4bbe5902ed2, topicName=无症状)], attachment=null, authenticateStatus=null, createdAvatar=Bioon/avatar/20180429/70baad2aa5a046c5aa2914d262de7d37.jpg, createdBy=bd077990475, createdName=12498da4m34(暂无昵称), createdTime=Fri Mar 18 22:40:10 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1526013, encodeId=52771526013a4, content=<a href='/topic/show?id=81c93e74709' target=_blank style='color:#2F92EE;'>#反弹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37747, encryptionId=81c93e74709, topicName=反弹)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17d711676114, createdName=meichuangyi, createdTime=Fri Mar 18 22:40:10 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203423, encodeId=74b812034235a, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/wrK88GbrwEH7IX8Qn6JNW417PI4aA1anS5cHVdzQnhC03fef3DsbXtkdx0a84diaAztGjAJlnOsiaqiaYDW2ibK8iaw/132, createdBy=ecbc5135505, createdName=13746658d9m, createdTime=Thu Mar 17 12:46:56 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203412, encodeId=381d1203412b6, content=<a href='/topic/show?id=8a4e10443423' target=_blank style='color:#2F92EE;'>#奥密克戎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104434, encryptionId=8a4e10443423, topicName=奥密克戎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Thu Mar 17 11:45:50 CST 2022, time=2022-03-17, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1334933, encodeId=a471133493302, content=<a href='/topic/show?id=d16910002215' target=_blank style='color:#2F92EE;'>#韩国#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100022, encryptionId=d16910002215, topicName=韩国)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99cf2500102, createdName=zjshifan_98647306, createdTime=Fri Mar 18 22:40:10 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1339447, encodeId=907c133944e2f, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63054, encryptionId=447663054f5, topicName=欧洲)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKxsKDoOOFxGpMibw6lsQFUIicWt7kWGevkdgFhjiban1icD2JdIBmjVo7qX7aSlCSpiaia382nuLKiaI3Cg/132, createdBy=5c442500150, createdName=ms9474365431325850, createdTime=Fri Mar 18 22:40:10 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1485247, encodeId=312b148524e86, content=<a href='/topic/show?id=4bbe5902ed2' target=_blank style='color:#2F92EE;'>#无症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59027, encryptionId=4bbe5902ed2, topicName=无症状)], attachment=null, authenticateStatus=null, createdAvatar=Bioon/avatar/20180429/70baad2aa5a046c5aa2914d262de7d37.jpg, createdBy=bd077990475, createdName=12498da4m34(暂无昵称), createdTime=Fri Mar 18 22:40:10 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1526013, encodeId=52771526013a4, content=<a href='/topic/show?id=81c93e74709' target=_blank style='color:#2F92EE;'>#反弹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37747, encryptionId=81c93e74709, topicName=反弹)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17d711676114, createdName=meichuangyi, createdTime=Fri Mar 18 22:40:10 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203423, encodeId=74b812034235a, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/wrK88GbrwEH7IX8Qn6JNW417PI4aA1anS5cHVdzQnhC03fef3DsbXtkdx0a84diaAztGjAJlnOsiaqiaYDW2ibK8iaw/132, createdBy=ecbc5135505, createdName=13746658d9m, createdTime=Thu Mar 17 12:46:56 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203412, encodeId=381d1203412b6, content=<a href='/topic/show?id=8a4e10443423' target=_blank style='color:#2F92EE;'>#奥密克戎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104434, encryptionId=8a4e10443423, topicName=奥密克戎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Thu Mar 17 11:45:50 CST 2022, time=2022-03-17, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1334933, encodeId=a471133493302, content=<a href='/topic/show?id=d16910002215' target=_blank style='color:#2F92EE;'>#韩国#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100022, encryptionId=d16910002215, topicName=韩国)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99cf2500102, createdName=zjshifan_98647306, createdTime=Fri Mar 18 22:40:10 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1339447, encodeId=907c133944e2f, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63054, encryptionId=447663054f5, topicName=欧洲)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKxsKDoOOFxGpMibw6lsQFUIicWt7kWGevkdgFhjiban1icD2JdIBmjVo7qX7aSlCSpiaia382nuLKiaI3Cg/132, createdBy=5c442500150, createdName=ms9474365431325850, createdTime=Fri Mar 18 22:40:10 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1485247, encodeId=312b148524e86, content=<a href='/topic/show?id=4bbe5902ed2' target=_blank style='color:#2F92EE;'>#无症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59027, encryptionId=4bbe5902ed2, topicName=无症状)], attachment=null, authenticateStatus=null, createdAvatar=Bioon/avatar/20180429/70baad2aa5a046c5aa2914d262de7d37.jpg, createdBy=bd077990475, createdName=12498da4m34(暂无昵称), createdTime=Fri Mar 18 22:40:10 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1526013, encodeId=52771526013a4, content=<a href='/topic/show?id=81c93e74709' target=_blank style='color:#2F92EE;'>#反弹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37747, encryptionId=81c93e74709, topicName=反弹)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17d711676114, createdName=meichuangyi, createdTime=Fri Mar 18 22:40:10 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203423, encodeId=74b812034235a, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/wrK88GbrwEH7IX8Qn6JNW417PI4aA1anS5cHVdzQnhC03fef3DsbXtkdx0a84diaAztGjAJlnOsiaqiaYDW2ibK8iaw/132, createdBy=ecbc5135505, createdName=13746658d9m, createdTime=Thu Mar 17 12:46:56 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203412, encodeId=381d1203412b6, content=<a href='/topic/show?id=8a4e10443423' target=_blank style='color:#2F92EE;'>#奥密克戎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104434, encryptionId=8a4e10443423, topicName=奥密克戎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Thu Mar 17 11:45:50 CST 2022, time=2022-03-17, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1334933, encodeId=a471133493302, content=<a href='/topic/show?id=d16910002215' target=_blank style='color:#2F92EE;'>#韩国#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100022, encryptionId=d16910002215, topicName=韩国)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99cf2500102, createdName=zjshifan_98647306, createdTime=Fri Mar 18 22:40:10 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1339447, encodeId=907c133944e2f, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63054, encryptionId=447663054f5, topicName=欧洲)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKxsKDoOOFxGpMibw6lsQFUIicWt7kWGevkdgFhjiban1icD2JdIBmjVo7qX7aSlCSpiaia382nuLKiaI3Cg/132, createdBy=5c442500150, createdName=ms9474365431325850, createdTime=Fri Mar 18 22:40:10 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1485247, encodeId=312b148524e86, content=<a href='/topic/show?id=4bbe5902ed2' target=_blank style='color:#2F92EE;'>#无症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59027, encryptionId=4bbe5902ed2, topicName=无症状)], attachment=null, authenticateStatus=null, createdAvatar=Bioon/avatar/20180429/70baad2aa5a046c5aa2914d262de7d37.jpg, createdBy=bd077990475, createdName=12498da4m34(暂无昵称), createdTime=Fri Mar 18 22:40:10 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1526013, encodeId=52771526013a4, content=<a href='/topic/show?id=81c93e74709' target=_blank style='color:#2F92EE;'>#反弹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37747, encryptionId=81c93e74709, topicName=反弹)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17d711676114, createdName=meichuangyi, createdTime=Fri Mar 18 22:40:10 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203423, encodeId=74b812034235a, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/wrK88GbrwEH7IX8Qn6JNW417PI4aA1anS5cHVdzQnhC03fef3DsbXtkdx0a84diaAztGjAJlnOsiaqiaYDW2ibK8iaw/132, createdBy=ecbc5135505, createdName=13746658d9m, createdTime=Thu Mar 17 12:46:56 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203412, encodeId=381d1203412b6, content=<a href='/topic/show?id=8a4e10443423' target=_blank style='color:#2F92EE;'>#奥密克戎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104434, encryptionId=8a4e10443423, topicName=奥密克戎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Thu Mar 17 11:45:50 CST 2022, time=2022-03-17, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1334933, encodeId=a471133493302, content=<a href='/topic/show?id=d16910002215' target=_blank style='color:#2F92EE;'>#韩国#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100022, encryptionId=d16910002215, topicName=韩国)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99cf2500102, createdName=zjshifan_98647306, createdTime=Fri Mar 18 22:40:10 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1339447, encodeId=907c133944e2f, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63054, encryptionId=447663054f5, topicName=欧洲)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKxsKDoOOFxGpMibw6lsQFUIicWt7kWGevkdgFhjiban1icD2JdIBmjVo7qX7aSlCSpiaia382nuLKiaI3Cg/132, createdBy=5c442500150, createdName=ms9474365431325850, createdTime=Fri Mar 18 22:40:10 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1485247, encodeId=312b148524e86, content=<a href='/topic/show?id=4bbe5902ed2' target=_blank style='color:#2F92EE;'>#无症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59027, encryptionId=4bbe5902ed2, topicName=无症状)], attachment=null, authenticateStatus=null, createdAvatar=Bioon/avatar/20180429/70baad2aa5a046c5aa2914d262de7d37.jpg, createdBy=bd077990475, createdName=12498da4m34(暂无昵称), createdTime=Fri Mar 18 22:40:10 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1526013, encodeId=52771526013a4, content=<a href='/topic/show?id=81c93e74709' target=_blank style='color:#2F92EE;'>#反弹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37747, encryptionId=81c93e74709, topicName=反弹)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17d711676114, createdName=meichuangyi, createdTime=Fri Mar 18 22:40:10 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203423, encodeId=74b812034235a, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/wrK88GbrwEH7IX8Qn6JNW417PI4aA1anS5cHVdzQnhC03fef3DsbXtkdx0a84diaAztGjAJlnOsiaqiaYDW2ibK8iaw/132, createdBy=ecbc5135505, createdName=13746658d9m, createdTime=Thu Mar 17 12:46:56 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203412, encodeId=381d1203412b6, content=<a href='/topic/show?id=8a4e10443423' target=_blank style='color:#2F92EE;'>#奥密克戎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104434, encryptionId=8a4e10443423, topicName=奥密克戎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Thu Mar 17 11:45:50 CST 2022, time=2022-03-17, status=1, ipAttribution=)]
    2022-03-17 13746658d9m

    学习

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1334933, encodeId=a471133493302, content=<a href='/topic/show?id=d16910002215' target=_blank style='color:#2F92EE;'>#韩国#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100022, encryptionId=d16910002215, topicName=韩国)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99cf2500102, createdName=zjshifan_98647306, createdTime=Fri Mar 18 22:40:10 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1339447, encodeId=907c133944e2f, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63054, encryptionId=447663054f5, topicName=欧洲)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKxsKDoOOFxGpMibw6lsQFUIicWt7kWGevkdgFhjiban1icD2JdIBmjVo7qX7aSlCSpiaia382nuLKiaI3Cg/132, createdBy=5c442500150, createdName=ms9474365431325850, createdTime=Fri Mar 18 22:40:10 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1485247, encodeId=312b148524e86, content=<a href='/topic/show?id=4bbe5902ed2' target=_blank style='color:#2F92EE;'>#无症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59027, encryptionId=4bbe5902ed2, topicName=无症状)], attachment=null, authenticateStatus=null, createdAvatar=Bioon/avatar/20180429/70baad2aa5a046c5aa2914d262de7d37.jpg, createdBy=bd077990475, createdName=12498da4m34(暂无昵称), createdTime=Fri Mar 18 22:40:10 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1526013, encodeId=52771526013a4, content=<a href='/topic/show?id=81c93e74709' target=_blank style='color:#2F92EE;'>#反弹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37747, encryptionId=81c93e74709, topicName=反弹)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17d711676114, createdName=meichuangyi, createdTime=Fri Mar 18 22:40:10 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203423, encodeId=74b812034235a, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/wrK88GbrwEH7IX8Qn6JNW417PI4aA1anS5cHVdzQnhC03fef3DsbXtkdx0a84diaAztGjAJlnOsiaqiaYDW2ibK8iaw/132, createdBy=ecbc5135505, createdName=13746658d9m, createdTime=Thu Mar 17 12:46:56 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203412, encodeId=381d1203412b6, content=<a href='/topic/show?id=8a4e10443423' target=_blank style='color:#2F92EE;'>#奥密克戎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104434, encryptionId=8a4e10443423, topicName=奥密克戎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Thu Mar 17 11:45:50 CST 2022, time=2022-03-17, status=1, ipAttribution=)]

相关资讯

2022年3月13日简报:香港新增15789例确诊病例,疫情快速回落;英国新冠病死率与流感相当;韩国新增38万例病例,死亡269人;吉林省单日新增本土新冠肺炎确诊病例1412例

截至北京时间2022年3月13日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过4亿5630万例,新增1,248,418例,达到456,306

新冠病毒快速抗原检测对奥密克戎等变异株的敏感性如何?

自新冠病毒(SARS-CoV-2)出现以来,已经开发出了各种各样的诊断方法。这些检测方法主要使用实时定量逆转录聚合酶链反应(qRT-PCRs)来检测病毒RNA。

2022年3月16日简报:更新版新冠诊疗法方案公布,对轻症不必收治于定点医院;80%到90%奥密克戎感染者都是无症状的携带者;

截至北京时间2022年3月16日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过4亿6135万例,新增1,578,715例,达到461,353

2022年3月15日简报:疫情期间,新加坡总体死亡反而减少;泰国发现奥密克戎亚型变异株BA.2.2;上海昨日新增本土新冠肺炎9+130例

截至北京时间2022年3月15日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过4亿5921万例,新增972,253例,达到459,217,7

medRxiv:新冠病毒快速抗原检测对奥密克戎等变异株的敏感性如何?

该试验显示,检测新冠病毒与包括奥密克戎在内的所有变异株之间的敏感性相当。

英国新冠死亡率降至0.03%,低于流感,率先实现「与新冠共存」

据英国《每日邮报》3月10日报道,由于奥密克戎的温和性和极高的免疫率,新冠病毒在英国的致死率(Fatality Rate)已低于流感。